Geode Capital Management, LLC Infla Rx N.V. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Geode Capital Management, LLC holds 43,672 shares of IFRX stock, worth $59,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,672

Previous 48,136 9.27%

Holding current value

$59,393

Previous $49,000 30.61%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$0.73 - $1.85 $3,258 - $8,258	-4,464 Reduced 9.27%	43,672 $34,000
Q4 2024 Feb 12, 2025	BUY	$1.38 - $2.64 $16,422 - $31,416	11,900 Added 32.84%	48,136 $119,000
Q3 2023 Nov 13, 2023	BUY	$2.66 - $4.33 $13,145 - $21,398	4,942 Added 15.79%	36,236 $107,000
Q2 2023 Aug 11, 2023	BUY	$2.05 - $6.1 $10,182 - $30,298	4,967 Added 18.87%	31,294 $139,000
Q1 2022 May 13, 2022	BUY	$1.83 - $4.48 $13,424 - $32,865	7,336 Added 38.63%	26,327 $48,000
Q3 2021 Nov 12, 2021	BUY	$2.25 - $3.03 $42,729 - $57,542	18,991 New	18,991 $49,000
Q4 2020 Feb 12, 2021	SELL	$3.82 - $5.32 $55,451 - $77,225	-14,516 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.7 - $5.47 $65,075 - $96,206	-17,588 Reduced 54.78%	14,516 $61,000
Q2 2020 Aug 13, 2020	SELL	$4.59 - $8.96 $267,776 - $522,717	-58,339 Reduced 64.5%	32,104 $147,000
Q1 2020 May 14, 2020	BUY	$2.65 - $6.08 $7,059 - $16,197	2,664 Added 3.03%	90,443 $345,000
Q4 2019 Feb 13, 2020	BUY	$2.2 - $4.54 $161,178 - $332,614	73,263 Added 504.71%	87,779 $347,000
Q2 2019 Aug 14, 2019	BUY	$3.06 - $51.61 $3,558 - $60,022	1,163 Added 8.71%	14,516 $45,000
Q1 2019 May 14, 2019	BUY	$31.16 - $48.62 $206,590 - $322,350	6,630 Added 98.62%	13,353 $504,000
Q4 2018 Feb 13, 2019	SELL	$23.33 - $36.37 $1.71 Million - $2.67 Million	-73,504 Reduced 91.62%	6,723 $244,000
Q3 2018 Nov 13, 2018	BUY	$29.34 - $35.0 $1.25 Million - $1.49 Million	42,599 Added 113.21%	80,227 $2.75 Million
Q2 2018 Aug 14, 2018	BUY	$27.33 - $41.46 $35,610 - $54,022	1,303 Added 3.59%	37,628 $1.21 Million
Q1 2018 May 15, 2018	BUY	$20.21 - $32.0 $734,128 - $1.16 Million	36,325 New	36,325 $1.05 Million

Others Institutions Holding IFRX

# of Institutions

Shares Held

17.3M

Call Options Held

32.7K

Put Options Held

View Full List

About InflaRx N.V.

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $60.1M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

More about IFRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Infla Rx N.V. Transaction History